Financial Statements

Regencell Bioscience Holdings Limit... (RGC)


0.00 (0.00%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2022 2021 2020 2019 2017
Retained Earnings (Previous Year) -4-3-2--
Net Income -7-1-1-0112
Stock Dividends ----198
Dividend Paid -----139
Retained Earnings -11-4-3-271

PPE Schedule

Year 2022 2021 2020 2019 2017
Gross PPE 00---
Annual Depreciation 2-00-1,764
Capital Expenditure -1--0--250
Net PPE 100-1,513

Intangible and Goodwill Schedule

Year 2022 2021 2020 2019 2017
Intangible and Goodwill (Previous Year) -----
New Purchases -----10
Intangible and Goodwill 346----

Regencell Bioscience Holdings Limited income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Regencell Bioscience Holdings Limited FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.